Sage Journals: Discover world-class research

Abstract

Get full access to this article

View all access options for this article.

References

US Food and Drug Administration. FDA Oncology Center of Excellence patient-focused drug development program, https://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/OCE/ucm544143.htm (accessed 15 June 2017).

Heath

Heeney

Hoppe

et al . Successful utilization of an electronic pain diary in a multinational phase 3 interventional study of pediatric sickle cell anemia. Clin Trials, IN PRESS.

Charache

Terrin

Moore

et al . Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med 1995; 332: 1317–1322.

Bristol-Myers Squibb Company. Droxia (package insert) 2016. New Brunswick, NJ: Bristol-Myers Squibb Company.

Maxwell

Streetly

Bevan

. Experiences of hospital care and treatment seeking for pain from sickle cell disease: qualitative study. BMJ 1999; 318: 1585–1590.

US Food and Drug Administration’s Patient-Focused Drug Development Initiative. The voice of the patient: sickle cell disease, https://www.fda.gov/downloads/ForIndustry/UserFees/PrescriptionDrugUserFee/UCM418430.pdf (2014, accessed 19 June 2017).

Haywood

Lanzkron

Ratanawongsa

et al . Hospital self-discharge among adults with sickle-cell disease (SCD): associations with trust and interpersonal experiences with care. J Hosp Med 2010; 5: 289–294.

Smith

Penberthy

Bovbjerg

et al . Daily assessment of pain in adults with sickle cell disease. Ann Intern Med 2008; 148: 94–101.

US Food and Drug Administration. Guidance for industry, patient-reported outcome measures: use in medical product development to support labeling claims, https://www.fda.gov/ucm/groups/fdagov-public/@fdagov-drugs-gen/documents/document/ucm193282.pdf (2009, accessed 20 June 2017).

10.

Matza

Patrick

Riley

et al . Pediatric patient-reported outcome instruments for research to support medical product labeling: report of the ISPOR PRO good research practices for the assessment of children and adolescents task force. Value Health 2013; 16: 461–479.

11.

Huang

Revicki

Schwartz

. Measuring pediatric patient-reported outcomes: good progress but a long way to go. Qual Life Res 2014; 23: 747–750.

12.

Sun

Papadopoulos

Hyams

et al . Well-defined and reliable clinical outcome assessments for pediatric Crohn disease: a critical need for drug development. J Pediatr Gastroenterol Nutr 2015; 60: 729–736.

13.

Kabali

Irigoyen

Nunez-Davis

et al . Exposure and use of mobile media devices by young children. Pediatrics 2015; 136: 1044–1050.

14.

Reeve

Withycombe

Baker

et al . The first step to integrating the child’s voice in adverse event reporting in oncology trials: a content validation study among pediatric oncology clinicians. Pediatr Blood Cancer 2013; 60: 1231–1236.

Commentary on Heath et al.

Abstract

Get full access to this article

References